Potential of GLP-1 Agonists To Help Patients with Binge Eating Disorders
Potential of GLP-1 Agonists To Help Patients with Binge Eating Disorders
Information
Date & Time
-
-
Description
The course examines the intersection of GLP-1 and binge eating behaviors. The course will start with a description of the many roles of GLP-1 in the body including eating behaviors and metabolism. A potential link between low GLP-1 and the development of binge eating behaviors will then be discussed. The second half of the presentation will review the FDA approved indications for GLP-1 medications and outline the potential use of GLP-1 medications to treat patients with conditions including Bulimia Nervosa and Binge Eating Disorder. An advocate with lived experience will then share their experience with the medication.
Educational Goal
Learning Objectives
Participants will be able to:
-
Outline the functions of GLP-1 after a meal within the body
-
Describe some of the genetic pathways linked to the risk of developing binge eating behaviors
-
Discuss expected benefits vs, potential risks of GLP-1 medications for patients with eating disorders
Target Audience
- Addiction Professional
- Counselor
- Dietitian
- Marriage & Family Therapist
- Nurse
- Nutritionist
- Physician
- Psychologist
- Social Worker
Presenters
Financially Sponsored By
- Lindner Center of Hope